Adoptive T-cell Therapy (virus-specific donor-derived T cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adoptive T-cell Therapy (virus-specific donor-derived T cells), covering 2024-12-27 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]